These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34081789)

  • 1. Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta-analysis.
    Tatum R; Maynes EJ; Wood CT; Deb AK; Austin MA; O'Malley TJ; Choi JH; Massey HT; Morris RJ; Pavri BB; Tchantchaleishvili V
    Pacing Clin Electrophysiol; 2021 Aug; 44(8):1297-1302. PubMed ID: 34081789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S; Doyle M; Krishnan K; Biederman RWW
    Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX; Wei M; Xiang R; Lu YM; Zhang L; Li YD; Zhang JH; Xing Q; Tu-Erhong ZK; Tang BP; Zhou XH
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1741-1755. PubMed ID: 34389210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC; Friedman SE; Kono AT; Greenberg ML; Palac RT
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF; Joseph J; Erqou SA; Kinlay S; Echouffo-Tcheugui JB; Peralta AO; Hoffmeister PS; Boden WE; Yarmohammadi H; Martin DT; Singh JP
    Europace; 2024 Jul; 26(7):. PubMed ID: 38812433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-Up of Mortality and Heart Failure Hospitalisation in Patients With Intracardiac Device-Related Tricuspid Regurgitation.
    Kanawati J; Ng ACC; Khan H; Yu C; Hyun K; Abed H; Kritharides L; Sy RW
    Heart Lung Circ; 2021 May; 30(5):692-697. PubMed ID: 33132050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP; Lew J; Yucel E; Singh J; Mela T
    J Cardiovasc Electrophysiol; 2024 May; 35(5):1017-1025. PubMed ID: 38501386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A
    Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H; Seo Y; Ishizu T; Iida N; Sato K; Yamamoto M; Machino-Ohtsuka T; Nogami A; Ohte N; Ieda M
    Circ J; 2020 Nov; 84(12):2302-2311. PubMed ID: 33071243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives.
    Chodór-Rozwadowska KE; Sawicka M; Morawski S; Lenarczyk R; Kalarus Z; Kukulski T
    Adv Clin Exp Med; 2023 Sep; 32(9):1049-1061. PubMed ID: 36881368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
    Addetia K; Harb SC; Hahn RT; Kapadia S; Lang RM
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):622-636. PubMed ID: 30947905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
    Wiechecka K; Wiechecki B; Kapłon-Cieślicka A; Tymińska A; Budnik M; Hołowaty D; Jakubowski K; Michalak M; Świętoń E; Stolarz P; Steckiewicz R; Grabowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Cardiol J; 2020; 27(6):797-806. PubMed ID: 31225634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Trial.
    Leong DP; Dokainish H; Mondésert B; Cavalli G; Khetan A; Cirne F; Baro Vila R; Klimis H; De Jesus TA; AlGhasab NS; Akbari V; Suliman A; Eltebi O; Almhri A; Ferdous T; Djuric A; Bashir J; Krahn AD; Exner DV; Philippon F; Birne DH; Joza J; Healey JS
    JACC Clin Electrophysiol; 2024 Sep; 10(9):2088-2096. PubMed ID: 39001765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
    Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.